SEEING TRIPLE
agency: Harrison and Star
brand: Avastin
client: Roche (Global) and Genentech (US)
photo from left: Craig Foster, partner, Inside Productions • Chris Watson, SVP, creative director • Alaina Mendoza, VP, group account supervisor • Michael Norkin, VP, associate creative director
The biggest hurdle facing any professional marketing team is making dry scientific facts and figures really pop. The team at Harrison and Star took that challenge literally—and in the process, combined cutting-edge graphics and stellar filmmaking to create 3-D animation of Avastin's mechanism of action.
Genentech was pleased, as was the industry—the Avastin DVD garnered high accolades from a variety of sources, including the Rx Club Awards. It also made a splash on the convention hall floor. (We've seen it—have you?)
"We know from experience that it's been very successful at conventions," says Michael Norkin of Harrison and Star. "It's facilitating one-to-one discussions at the booth."
The chance to don purple 3-D glasses and see some striking visuals may be what first grabs the audience's attention. But the sophisticated thrill-ride through the body and closeup of the drug's MOA is what keeps them watching. The DVD includes versions in English, German, Spanish, Italian, French, and Japanese, so professionals the world over can learn about anti-VEGF therapy while oohing and aahing at the visuals.
PREVIOUS AGENCY ‹‹ HOME ›› NEXT AGENCY
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.